In MDS cases with high ERFE expression the survival benefit might result from the fact that the damage in erythropoiesis is still limited enough to allow erythroid progenitors to better adapt to an anemic state, e.g. by upregulating ERFE. The gene discussed is ERFE; the disease is myelodysplastic syndrome.